Hospitals Segment to Dominate Europe Autotransfusion Devices Market during 2019–2028
According to The Insight Partners market research study on “Europe Autotransfusion Devices Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type, Application, and End User,” is expected to reach US$ 372.69 million by 2028 from US$ 289.67 million in 2021. The market is estimated to grow at a CAGR of 3.7% from 2021 to 2028. Rapid rise in chronic diseases is the major factor driving the growth of the Europe autotransfusion devices market. However, product recalls may hinder the growth of Europe autotransfusion devices market. The report provides trends prevailing in the Europe autotransfusion devices market along with the drivers and restraints pertaining to the market growth.
The Europe autotransfusion devices market is segmented into type, application, end user, and country. The Europe autotransfusion devices market, by type, is segmented into products and accessories. In 2021, the accessories segment held the largest share Europe autotransfusion devices market. The products is further sub-segmented into intraoperative autotransfusion systems, postoperative autotransfusion systems, and dual-mode autotransfusion systems. In 2021, the intraoperative autotransfusion systems segment held the largest share Europe autotransfusion devices market. The Europe autotransfusion devices market, by application, is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. The cardiac surgeries segment held the largest share of the market in 2021. Based on end user, the Europe autotransfusion devices market is segmented hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the market in 2021. Similarly, based on country, the Europe autotransfusion devices market is segmented into Germany, France, United Kingdom, Italy, Spain, and the rest of Europe. Germany contributed a substantial share in 2021.
BD, Braile Biomedica, Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax S.p.A., SARSTEDT AG and Co. KG, Teleflex Incorporated, and Zimmer Biomet are among the leading companies in the Europe autotransfusion devices market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, SARSTEDT AG and Co. KG acquired 80% of the shares in Timedico A/S and secured a right to acquire additional 20% soon. The acquisition has helped the company to leverage its value proposition to company's global customers.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com